Kyle Krisiloff, No. 14, Lilly/Walgreens, Bristol Post Race
FOR IMMEDIATE RELEASE BRAND NEW BRISTOL Krisiloff avoids cautions, finishes 26th on new track surface at BMS BRISTOL, Tenn. (August 25, 2007) Rookie Kyle Krisiloff, driver of the No. 14 Lilly/Walgreens Ford, posted a 26th place finish on Friday in his second career start at Bristol Motor Speedway. Krisiloff started the Food City 250 near the end of the tightly packed field after qualifying 33rd. When the second caution of the night was issued on lap 51, new crew chief Bryant Frazier brought the No. 14 machine down pit road for a few minor changes to loosen up the tight racecar. On lap 56, Krisiloff restarted one lap down in the 34th position after four tires, fuel and a slight wedge adjustment. The Lilly/Walgreens team remained focused, continuing to work hard to the improve racecar throughout the caution-filled race. Later their focus would pay off as Krisiloff earned the lucky dog award, putting the No. 14 Ford back on the lead lap in 27th for the restart. Being back on the lead lap gave the team a chance to work on pit strategies and prepare for the end of the race. The final pit stop of the night for the Lilly/Walgreens team came after the red flag delay from the lap 171 caution. Four tires and fuel were the only changes the pit crew made and Krisiloff lined up 26th for the restart. The closing laps of the race brought out two more cautions, but the Lilly/Walgreens team stayed out, opting to keep their track position as they anticipated the checkered flag. Krisiloff maintained his position, finishing 26th. ³It was a good first night with Bryant,² Krisiloff said. ³We took a pretty bad racecar and worked hard the whole race, both on the track and in the pits. We were able to see what would and wouldnıt work in Thursdayıs practice and apply it to the race tonight. We steadily gained track position by making improvements to the car. We can take what weıve learned here tonight and build for the future.² Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers through medicines and information for some of the worldıs most urgent medical needs. Additional information about Lilly is available at www.lilly.com <http://www.lilly.com/> . Walgreens Co. is the nationıs largest drugstore chain with fiscal 2006 sales of $47.4 billion. The company operates 5,850 stores in 48 states and Puerto Rico, including 77 Happy Harryıs drugstores in Delaware and surrounding states. Walgreens is expanding its patient-first health care services beyond traditional pharmacy through Walgreens Health Services, its managed convenient care clinics inside drugstores. Walgreens Health Services assists pharmacy patients and prescription drug and medical plans through Walgreens Health Initiatives, Inc. (a pharmacy benefits manager), Walgreens Mail Service Inc., Walgreens home Care Inc., and Walgreens Specialty Pharmacy. More information about Walgreens is available at www.walgreens.com <http://www.walgreens.com/> . Joslin Diabetes Center, affiliated with Harvard Medical School, has helped revolutionize the diagnosis, treatment and prevention of diabetes since itıs founding more than a century ago. Joslin is the worldıs largest diabetes research center, diabetes clinic, and provider of diabetes education, and its staff of renowned physicians, researchers and clinical specialists is dedicated to preventing and curing diabetes. Joslin and Walgreens have a multi-year partnership to develop and deliver awareness, wellness, prevention and education programs to Walgreens customers with diabetes. For more information on Joslin, call 1-800-JOSLIN-1 or visit www.joslin.org <http://www.joslin.org/> . Racing Against Diabetes, a public awareness campaign sponsored by Eli Lilly and Company and Walgreens, is designed to educate people at risk for and living with diabetes. Diabetes is the sixth leading cause of death in the United States, affecting nearly 21 million Americans; yet, one-third of those affected are unaware they have the disease. Seeking to build diabetes awareness both on and off the track, the Racing Against Diabetes campaign hosts diabetes education programs in NASCAR race markets across the country. The first cause-marketing effort of its kind in the NASCAR Busch Series, Racing Against Diabetes works alongside the Joslin Diabetes Center, the worldıs largest diabetes research center/clinic and provider of diabetes education. ### Contact: Shannon Blankenship, Cox Group (704) 896-2323 Shannon@coxgp.com